News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
161 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17865)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (249)
2 (227)
3 (175)
4 (72)
5 (2)
6 (9)
7 (175)
8 (219)
9 (161)
10 (259)
11 (113)
12 (7)
13 (2)
14 (172)
15 (304)
16 (260)
17 (238)
18 (120)
19 (1)
20 (3)
21 (214)
22 (269)
23 (243)
24 (278)
25 (118)
26 (3)
27 (18)
28 (238)
29 (307)
30 (277)
31 (323)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Advisory - Pharm Canada Inc. recalls all lots of “Passion X” and “Passion Fem” because they contain an undeclared prescription drug ingredient and may pose serious health risks
Health Canada is advising Canadians that Pharm Canada Inc. is recalling all lots of “Passion X” and “Passion Fem” from retail because they contain an undeclared prescription drug ingredient (sildenafil) and may pose serious health risks.
October 9, 2019
·
2 min read
Canfield Scientific Premieres New AI Solutions Including the Most Advanced Grading System for Suspicious Lesions - DEXI™ and the Fastest and Most Convenient Hair Consultation Solution - HairMetrix™
At the European Academy of Dermatology and Venereology annual meeting 10-12 October, in Madrid, Spain, Canfield Scientific will showcase several new, innovative AI-driven dermatology solutions along with significant enhancements to their aesthetic solutions.
October 9, 2019
·
2 min read
High-performance Liquid Chromatography (HPLC) Market 2019-2023 | Evolving Opportunities with Agilent Technologies, Inc. and GE Healthcare | Technavio
Technavio has been monitoring the global high-performance liquid chromatography market since 2016 and the market is poised to grow by USD 1.05 billion during 2019-2023, progressing at a CAGR of almost 5% during the forecast period.
October 9, 2019
·
4 min read
Business
OcuMedic, Inc. and Gelest, Inc. Enter Investment and Supply Agreement for Novel Contact Lens Drug Delivery System
“Working together with Gelest we will be better able to leverage the OcuMedic intellectual property into a wide variety of applications using OcuMedic’s proprietary platform technology,” said Keith D. Ignotz, President and Chief Executive Officer of OcuMedic, Inc.
October 9, 2019
·
5 min read
Biotech Beach
ImaginAb To Present At Innovation Showcase 2019 Hosted By The Lundquist Institute
Innovation Showcase 2019 on Monday, October 14, 2019, at The Lundquist Institute (formerly LA BioMed), 1124 West Carson Street, Torrance, CA.
October 9, 2019
·
3 min read
FDA
Beckman Coulter’s DxA 5000 total laboratory automation solution receives U.S. FDA 510(k) clearance
Research shows errors that occur in the pre-analytical phase of testing may contribute up to 75% of erroneous test results, with 26% possibly having an adverse effect on patient care.
October 9, 2019
·
5 min read
Business
Sean Hart Named Chief Business Officer of George Clinical
Hart, who joined George Clinical through the acquisition of Vector Oncology in 2017, will now lead business development functions globally for the organization.
October 9, 2019
·
2 min read
Genetown
Clinical Study Demonstrates Equally Impressive Outcomes for Any Condition of Glenoid Using The Arthrosurface OVO® with Inlay Glenoid Total Shoulder
Data published in Journal of Shoulder and Elbow Surgery found a significant improvement in range of motion and pain relief
October 9, 2019
·
3 min read
Job Trends
OrthoGrid Systems Selected as a 2019 Top 10 MedTech Startup by MedTech Outlook
Global leader in intelligent-guided technology selected as a top company for innovation in orthopedic surgery
October 9, 2019
·
1 min read
Lone Star Bio
Take Command Health Releases First ICHRA Affordability Calculator
Free tool helps employers determine minimum reimbursement amount to avoid penalties
October 9, 2019
·
2 min read
Previous
13 of 17
Next